Skip to main content
Top
Published in: Lung 6/2020

01-12-2020 | Dyspnea | Editorial

Is There (Will There Be) a Post-COVID-19 Chronic Cough?

Authors: Peter V. Dicpinigaitis, MD, Brendan J. Canning, PhD

Published in: Lung | Issue 6/2020

Login to get access

Excerpt

Cough is among the most common symptoms associated with an acute viral upper respiratory tract infection (URI; common cold). In the vast majority of afflicted persons, acute cough (defined as cough of less than 3 weeks’ duration) is transient and self-limited. However, in a subgroup of individuals recovering from a common cold syndrome, a dry, troublesome cough will persist as the sole residual symptom. Standard accepted terminology includes subacute cough as a cough lasting 3–8 weeks, and chronic cough greater than 8 weeks [1]. Indeed, clinicians treating patients with chronic cough will regularly obtain a history that the onset of chronic cough was temporally associated with an acute viral URI [2]. …
Literature
1.
go back to reference Morice AH, Millqvist E, Bieksiene K et al (2020) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 55:1901136CrossRef Morice AH, Millqvist E, Bieksiene K et al (2020) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 55:1901136CrossRef
2.
go back to reference Dicpinigaitis PV (2012) Thoughts on one thousand chronic cough patients. Lung 190:593–596CrossRef Dicpinigaitis PV (2012) Thoughts on one thousand chronic cough patients. Lung 190:593–596CrossRef
3.
go back to reference Footitt J, Johnston SL (2009) Cough and viruses in airways disease: mechanisms. Pulm Pharmacol Ther 22:108–113CrossRef Footitt J, Johnston SL (2009) Cough and viruses in airways disease: mechanisms. Pulm Pharmacol Ther 22:108–113CrossRef
4.
go back to reference Zaccone EJ, Undem BJ (2016) Airway vagal neuroplasticity associated with respiratory viral infections. Lung 194:25–29CrossRef Zaccone EJ, Undem BJ (2016) Airway vagal neuroplasticity associated with respiratory viral infections. Lung 194:25–29CrossRef
5.
go back to reference O’Connell F, Thomas VE, Studham JM et al (1996) Capsaicin cough sensitivity increases during upper respiratory infection. Respir Med 90:279–286CrossRef O’Connell F, Thomas VE, Studham JM et al (1996) Capsaicin cough sensitivity increases during upper respiratory infection. Respir Med 90:279–286CrossRef
6.
go back to reference Dicpinigaitis PV, Bhat R, Rhoton WA et al (2011) Effect of viral upper respiratory tract infection on the urge-to-cough sensation. Respir Med 105:615–618CrossRef Dicpinigaitis PV, Bhat R, Rhoton WA et al (2011) Effect of viral upper respiratory tract infection on the urge-to-cough sensation. Respir Med 105:615–618CrossRef
7.
go back to reference Dicpinigaitis PV, Tibb AS, Ramsey DL et al (2014) Stability of cough reflex sensitivity during viral upper respiratory tract infection (common cold). Pulm Pharmacol Ther 28:154–157CrossRef Dicpinigaitis PV, Tibb AS, Ramsey DL et al (2014) Stability of cough reflex sensitivity during viral upper respiratory tract infection (common cold). Pulm Pharmacol Ther 28:154–157CrossRef
8.
go back to reference Carfi A, Bernabei R, Landi F et al (2020) Persistent symptoms in patients after acute COVID19. JAMA 324:603–605CrossRef Carfi A, Bernabei R, Landi F et al (2020) Persistent symptoms in patients after acute COVID19. JAMA 324:603–605CrossRef
11.
go back to reference West PW, Canning BJ, Merlo-Pich E et al (2015) Morphologic characterization of nerves in whole-mount airway biopsies. Am J Respir Crit Care Med 192(1):30–39CrossRef West PW, Canning BJ, Merlo-Pich E et al (2015) Morphologic characterization of nerves in whole-mount airway biopsies. Am J Respir Crit Care Med 192(1):30–39CrossRef
12.
go back to reference Zaccone EJ, Lieu T, Muroi Y et al (2016) Parainfluenza 3-induced cough hypersensitivity in the guinea pig airways. PLoS One 11(5):e0155526CrossRef Zaccone EJ, Lieu T, Muroi Y et al (2016) Parainfluenza 3-induced cough hypersensitivity in the guinea pig airways. PLoS One 11(5):e0155526CrossRef
13.
go back to reference Deng Z, Zhou W, Sun J et al (2018) IFN-γ enhances the cough reflex sensitivity via calcium influx in vagal sensory neurons. Am J Respir Crit Care Med 198(7):868–879CrossRef Deng Z, Zhou W, Sun J et al (2018) IFN-γ enhances the cough reflex sensitivity via calcium influx in vagal sensory neurons. Am J Respir Crit Care Med 198(7):868–879CrossRef
16.
go back to reference Colarusso C, Terlizzi M, Pinto A et al (2020) A lesson from a saboteur: high-MW kininogen impact in coronavirus-induced disease 2019. Br J Pharmacol 177(21):4866–4872CrossRef Colarusso C, Terlizzi M, Pinto A et al (2020) A lesson from a saboteur: high-MW kininogen impact in coronavirus-induced disease 2019. Br J Pharmacol 177(21):4866–4872CrossRef
17.
go back to reference Garvin MR, Alvarez C, Miller JI et al (2020) A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife 9:e59177CrossRef Garvin MR, Alvarez C, Miller JI et al (2020) A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife 9:e59177CrossRef
18.
go back to reference Roche JA, Roche R (2020) A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications. FASEB J 34(6):7265–7269CrossRef Roche JA, Roche R (2020) A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications. FASEB J 34(6):7265–7269CrossRef
19.
go back to reference van de Veerdonk FL, Kouijzer IJE, de Nooijer AH et al (2020) Outcomes associated with use of a kinin B2 receptor antagonist among patients with COVID-19. JAMA Netw Open 3(8):e2017708CrossRef van de Veerdonk FL, Kouijzer IJE, de Nooijer AH et al (2020) Outcomes associated with use of a kinin B2 receptor antagonist among patients with COVID-19. JAMA Netw Open 3(8):e2017708CrossRef
20.
go back to reference van de Veerdonk FL, Netea MG, van Deuren M et al (2020) Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife 9:e57555CrossRef van de Veerdonk FL, Netea MG, van Deuren M et al (2020) Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife 9:e57555CrossRef
21.
go back to reference Hewitt MM, Adams G Jr, Mazzone SB et al (2016) Pharmacology of bradykinin-evoked coughing in guinea pigs. J Pharmacol Exp Ther 357(3):620–628CrossRef Hewitt MM, Adams G Jr, Mazzone SB et al (2016) Pharmacology of bradykinin-evoked coughing in guinea pigs. J Pharmacol Exp Ther 357(3):620–628CrossRef
22.
go back to reference Undem BJ, Chuaychoo B, Lee MG et al (2004) Subtypes of vagal afferent C-fibres in guinea-pig lungs. J Physiol 556(Pt 3):905–917CrossRef Undem BJ, Chuaychoo B, Lee MG et al (2004) Subtypes of vagal afferent C-fibres in guinea-pig lungs. J Physiol 556(Pt 3):905–917CrossRef
23.
go back to reference Chou YL, Scarupa MD, Mori N et al (2008) Differential effects of airway afferent nerve subtypes on cough and respiration in anesthetized guinea pigs. Am J Physiol Regul Integr Comp Physiol 295(5):R1572–R1584CrossRef Chou YL, Scarupa MD, Mori N et al (2008) Differential effects of airway afferent nerve subtypes on cough and respiration in anesthetized guinea pigs. Am J Physiol Regul Integr Comp Physiol 295(5):R1572–R1584CrossRef
24.
go back to reference Chou YL, Mori N, Canning BJ (2018) Opposing effects of bronchopulmonary C-fiber subtypes on cough in guinea pigs. Am J Physiol Regul Integr Comp Physiol 314(3):R489–R498CrossRef Chou YL, Mori N, Canning BJ (2018) Opposing effects of bronchopulmonary C-fiber subtypes on cough in guinea pigs. Am J Physiol Regul Integr Comp Physiol 314(3):R489–R498CrossRef
25.
go back to reference Tatar M, Webber SE, Widdicombe JG (1988) Lung C-fibre receptor activation and defensive reflexes in anaesthetized cats. J Physiol 402:411–420CrossRef Tatar M, Webber SE, Widdicombe JG (1988) Lung C-fibre receptor activation and defensive reflexes in anaesthetized cats. J Physiol 402:411–420CrossRef
26.
go back to reference Stone RA, Worsdell YM, Fuller RW et al (1993) Effects of 5-hydroxytryptamine and 5-hydroxytryptophan infusion on the human cough reflex. J Appl Physiol 74(1):396–401CrossRef Stone RA, Worsdell YM, Fuller RW et al (1993) Effects of 5-hydroxytryptamine and 5-hydroxytryptophan infusion on the human cough reflex. J Appl Physiol 74(1):396–401CrossRef
27.
go back to reference Tatar M, Sant’Ambrogio G, Sant’Ambrogio FB (1994) Laryngeal and tracheobronchial cough in anesthetized dogs. J Appl Physiol 76(6):2672–2679CrossRef Tatar M, Sant’Ambrogio G, Sant’Ambrogio FB (1994) Laryngeal and tracheobronchial cough in anesthetized dogs. J Appl Physiol 76(6):2672–2679CrossRef
Metadata
Title
Is There (Will There Be) a Post-COVID-19 Chronic Cough?
Authors
Peter V. Dicpinigaitis, MD
Brendan J. Canning, PhD
Publication date
01-12-2020
Publisher
Springer US
Published in
Lung / Issue 6/2020
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-020-00406-6

Other articles of this Issue 6/2020

Lung 6/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.